Phase I trial combining motexafin gadolinium with docetaxel in the treatment of advanced solid tumors.

被引：0
|
作者：
Phan, S
Messina, P
Buffan, M
Salemi, ML
Pandya, K
Wilmot, JP
机构：
[1] Pharmacycl Inc, Sunnyvale, CA USA
[2] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3203
引用
收藏
页码：244S / 244S
页数：1
相关论文
共 50 条
  • [21] Phase I trial of cabazitaxel plus cisplatin in patients with advanced solid tumors.
    Lockhart, Albert C.
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Lane, Alex R.
    Moseley, Jennifer L.
    Dedieu, Jean-Francois
    Stash, Diane
    Zhi, Xin
    Mazuir, Florent
    Mita, Alain C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [22] Phase I study of docetaxel (D), Carboplatin (C) and etoposide (E) in advanced solid tumors.
    Dunphy, F
    Dunleavy, T
    Cantrell, C
    Visconti, J
    Richart, J
    Pincus, S
    Petruska, P
    ANNALS OF ONCOLOGY, 2000, 11 : 135 - 135
  • [23] Phase I trial of motexafin gadolinium in combination with docetaxel and cisplatin for the treatment of non-small cell lung cancer
    William, William N.
    Zinner, Ralph G.
    Karp, Daniel D.
    Oh, Yun W.
    Glisson, Bonnie S.
    Phan, See-Chun
    Stewart, David J.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : 745 - 750
  • [24] Phase I pharmacokinetic (PK) study of daily imatinib in combination with docetaxel for patients with advanced solid tumors.
    Chatta, GS
    Fakih, M
    Ramalingam, S
    Belani, CP
    Ramanathan, RK
    Zamboni, N
    Friedland, D
    Lis, D
    Tutchko, S
    Egorin, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 138S - 138S
  • [25] Phase I study of ispinesib (SB-715992) in combination with docetaxel in patients with advanced solid tumors.
    Blagden, S
    Seebaran, A
    Molife, R
    Payne, M
    Reid, A
    Protheroe, A
    Kathman, S
    Williams, D
    Bowen, C
    Hodge, J
    Dar, M
    de-Bono, J
    Middleton, M
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9119S - 9119S
  • [26] Phase I trial of Amplimexon™ (imexon, inj.) in patients with advanced solid tumors.
    Dragovich, T
    Mendelson, D
    Gordon, M
    Wong, L
    Dorr, R
    Chow, S
    Grenier, K
    Hersh, E
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9122S - 9122S
  • [27] CTEP #8850: A phase I trial of riluzole and sorafenib in patients with advanced solid tumors.
    Spencer, Kristen Renee
    Mehnert, Janice M.
    Tan, Antoinette R.
    Moss, Rebecca Anne
    Levinson, Kelly
    Stein, Mark N.
    Huzzy, Lien
    Kane, Michael P.
    Gibbon, Darlene
    Wright, John Joseph
    Aisner, Joseph
    DiPaola, Robert S.
    Chen, Suzie
    Wen, Yvonne
    Goydos, James
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] Phase I study of regorafenib and sildenafil in advanced solid tumors.
    Poklepovic, Andrew Stewart
    Gordon, Sarah W.
    McGuire, William P.
    Thacker, Leroy R.
    Deng, Xiaoyan
    Tombes, Mary Beth
    Shrader, Ellen
    Ryan, Alison A.
    Kmieciak, Maciej
    Dent, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Phase I study of pemetrexed and sorafenib in advanced solid tumors.
    Poklepovic, Andrew Stewart
    Shafer, Danielle A.
    Roberts, John D.
    Geyer, Charles E.
    Dent, Paul
    Moran, Richard
    Tombes, Mary Beth
    Shrader, Ellen
    Strickler, Kathryn
    Wan, Wen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] A Phase I trial of weekly docetaxel and topotecan for solid tumors
    Lim, Wan Teck
    Baggstrom, Maria Q.
    Read, William
    Fracasso, Paula M.
    Govindan, Ramaswamy
    ACTA ONCOLOGICA, 2008, 47 (02) : 311 - 315
12345